Loss of BMP7 results in brown fat hypoplasia and reduced UCP1 levels [158], whereas systemic BMP7 administration increases BAT mass and thermogenic capacity, highlighting its therapeutic potential in obesity [159]. Here, BMP7 is linked to obesity due to melanocortin 4 receptor deficiency.